Macrilen
Payments companies reported to CMS as associated with Macrilen. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Macrilen, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Macrilen
These are the largest totals companies reported as associated with Macrilen. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Lisa Abbott | Reno, NV | Endocrinology, Diabetes & Metabolism | $82.83 |
| Anthony Heaney | Los Angeles, CA | Endocrinology, Diabetes & Metabolism | $66.70 |
| Brian Michael | Gettysburg, PA | Endocrinology, Diabetes & Metabolism | $52.01 |
| Christine Burns | Reno, NV | Medical | $24.13 |
| Amy Quigley | Reno, NV | Nurse Practitioner | $24.12 |
| Sonum Singh | Springfield, PA | Endocrinology, Diabetes & Metabolism | $23.06 |
| Jeffrey Freeman | Springfield, PA | Endocrinology, Diabetes & Metabolism | $23.06 |
| Murray Gordon | Pittsburgh, PA | Endocrinology, Diabetes & Metabolism | $19.36 |
| Patricia Mareda | Pittsburgh, PA | Family | $19.36 |
| Matthew Surgan | East Brunswick, NJ | Endocrinology, Diabetes & Metabolism | $18.57 |
Prescribed Macrilen?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.